(Circulation. 1999;100:940-943.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medicine, Stanford University School of Medicine, Stanford, Calif.
Correspondence to Gerald M. Reaven, MD, Shaman Pharmaceuticals, Inc, 213 E Grand Ave, South San Francisco, CA 94080-4812.
BackgroundThis study was initiated to compare the adherence to cultured endothelial cells of mononuclear cells isolated from normotensive and hypertensive individuals.
Methods and ResultsMononuclear cell binding to endothelium was greater in patients with hypertension (32±1 versus 25±2; P<0.001) than in normal volunteers. There was a significant relationship (r=0.42, P<0.01) between mononuclear cell binding and mean arterial pressure, independent of differences in age, sex, and body mass index. A significant relationship also existed between insulin resistance (estimated by the steady-state plasma glucose concentration during the insulin suppression test) and mononuclear cell binding in both the normotensive (r=0.86, P<0.001) and hypertensive (r=0.74, P<0.001) groups. Furthermore, multiple regression analysis demonstrated an independent relationship (P<0.001) between mononuclear cell binding and both steady-state plasma glucose and hypertensive status.
ConclusionsThese results indicate that both hypertension and insulin resistance lead to changes in mononuclear cells that increase their adherence to cultured endothelial cells.
Key Words: cells endothelium hypertension insulin
This article has been cited by other articles:
![]() |
A. M. Whetzel, D. T. Bolick, and C. C. Hedrick Sphingosine-1-phosphate inhibits high glucose-mediated ERK1/2 action in endothelium through induction of MAP kinase phosphatase-3 Am J Physiol Cell Physiol, February 1, 2009; 296(2): C339 - C345. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies Cardiovasc Res, May 1, 2008; 78(2): 265 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sydow, C. E Mondon, and J. P Cooke Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA Vascular Medicine, July 1, 2005; 10(1_suppl): S35 - S43. [Abstract] [PDF] |
||||
![]() |
K. Sydow, C. E Mondon, and J. P Cooke Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA Vascular Medicine, May 1, 2005; 10(2_suppl): S35 - S43. [Abstract] [PDF] |
||||
![]() |
G. M. Reaven Insulin Resistance/Compensatory Hyperinsulinemia, Essential Hypertension, and Cardiovascular Disease J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2399 - 2403. [Full Text] [PDF] |
||||
![]() |
G. Reaven and P. S. Tsao Insulin resistance and compensatory hyperinsulinemia: The key player between cigarette smoking and cardiovascular disease? J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1044 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Stuhlinger, F. Abbasi, J. W. Chu, C. Lamendola, T. L. McLaughlin, J. P. Cooke, G. M. Reaven, and P. S. Tsao Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor JAMA, March 20, 2002; 287(11): 1420 - 1426. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |